Back to search

Trilogy Pharm Ltd

15146933

active
Private Limited Company
Companies House
Health Score
62 / 100

Some Concerns

30/30
Filing
0/30
Financial
32/40
Risk
  • Negative net worth (-10)
  • Current liabilities exceed current assets (-10)
  • Going concern doubt noted in accounts (-10)
  • 4 outstanding charges (-8)

Details

OFFICE 1, WALSALL, WS4 2LA
Incorporated 19/09/2023

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

47730
Dispensing chemist in specialised stores

Officers

Mr Hurkamal Michael Badhan

director · Since 19/09/2023

PHARMACIST

BRITISH · ENGLAND · Age 35

Also on 3 other boards

Mr Arandeep Singh Bassi

director · Since 19/09/2023

PHARMACIST

BRITISH · UNITED KINGDOM · Age 33

Also on 3 other boards

Persons with Significant Control

Tcp Partnerships Limited

25–50% shares
25–50% votes

Office 1, 21 Hatherton Street, Walsall, WS4 2LA

Reg: 14516222 · Companies House · Director

Notified 19/09/2023

Hmb Pharma Ltd

25–50% shares
25–50% votes

Office 1 Hatherton Court, 21 Hatherton Street, Walsall, WS4 2LA

Reg: 15265381 · Registrar Of Companies (England And Wales) · Private Limited Company

Notified 11/12/2023

Asb Pharma Ltd

25–50% shares
25–50% votes

Office 1, 21 Hatherton Street, Walsall, WS4 2LA

Reg: 15277730 · Registrar Of Companies (England And Wales) · Private Limited Company

Notified 11/12/2023

Former PSCs

Mr Arandeep Singh Bassi

Ceased 11/12/2023

Mr Hurkamal Michael Badhan

Ceased 11/12/2023

Charges4 outstanding

Charge
outstanding

TSB BANK PLC

Created 01/08/2024Registered 03/08/2024
Charge
outstanding

TSB BANK PLC

Created 24/07/2024Registered 26/07/2024
Charge
outstanding

TSB BANK PLC

Created 24/07/2024Registered 26/07/2024
Charge
satisfied

TSB BANK PLC

Created 16/04/2024Registered 18/04/2024Satisfied 23/04/2024
Charge
outstanding

TSB BANK PLC

Created 16/04/2024Registered 17/04/2024

CompanyRankvs 4664+ SIC 47730 peers
19

Financial strength10th percentile among SIC peers · 3/25
Employees81th percentile among SIC peers · 12/15
LiquidityCurrent ratio 0.5× · 6/20
Longevity3 years trading (max 15) · 3/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10Outstanding charges -10
Show leaderboard
How is this score calculated?
Financial strength3/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees12/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity6/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity3/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. 2.2. Going Concern Disclosure The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going

Key FinancialsYear ending 31/07/2025

Net Worth

-£6k

Balance sheet strength

Cash

£100k

Cash in the bank

Net Current Assets

-£333k

Working capital

Current Assets

£335k

Current Liabilities

£667k

Fixed Assets

£868k

Debtors

£173k

11avg. employees

Balance Sheet

Intangible assets£771k
Assets less current liabilities£535k
Signed by Mr Arandeep Bassi 12/02/2026Prepared with Acorah Software Products - Accounts Production

EstimatesDerived

YearCurrent Ratio
20250.50

Derived from filed accounts. Not audited figures.